Related Experiment Video

Updated: Jun 2, 2026

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
11:11

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning

Published on: February 17, 2016

Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian

O Gomez1, A Sanchez-Rodriguez, Mqu Le

  • 1Laboratory of Neuroinflammation, Unidad de Neurologia Experimental, Hospital Nacional de Parapléjicos (SESCAM), Toledo, Spain.

British Journal of Pharmacology
|April 13, 2011
PubMed
Abstract

Insights

Synthetic cannabinoids activate cannabinoid receptors (CB1/CB2), accelerating oligodendrocyte differentiation via PI3K/Akt and mTOR pathways. This study highlights potential therapeutic targets for myelin repair.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • The endogenous cannabinoid system influences oligodendrocyte progenitor cell (OPC) differentiation.
  • Understanding the impact of synthetic cannabinoids on this process is crucial for potential therapeutic applications.

Purpose of the Study:

  • To investigate the effects of synthetic cannabinoid receptor agonists and antagonists on oligodendrocyte differentiation.
  • To elucidate the involvement of the PI3K/Akt and mTOR signaling pathways in cannabinoid-mediated OPC maturation.

Main Methods:

  • Primary OPCs were treated with selective CB(1), CB(2), and CB(1)/CB(2) receptor agonists (ACEA, JWH133, HU210) and antagonists (AM281, AM630).
  • The activation of PI3K/Akt and mTOR pathways was assessed by measuring Akt and mTOR phosphorylation.
  • Involvement of these pathways was confirmed using specific inhibitors (LY294002 for PI3K/Akt, rapamycin for mTOR).

Main Results:

  • CB(1) and CB(2) receptor activation by agonists significantly enhanced OPC differentiation, indicated by increased expression of stage-specific antigens and myelin basic protein (MBP).
  • The pro-differentiation effects of agonists were reversed by specific CB receptor antagonists.
  • Agonist treatment led to time-dependent phosphorylation of Akt and mTOR, which was inhibited by LY294002 and rapamycin, respectively.

Conclusions:

  • Activation of cannabinoid CB(1) or CB(2) receptors accelerates oligodendrocyte differentiation.
  • This acceleration is mediated through the PI3K/Akt and mTOR signaling cascades.
  • These findings suggest a potential role for cannabinoid receptor modulation in promoting myelin repair.

More Related Videos

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions10:53

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions

Published on: November 9, 2020

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...